Seeking Alpha

Mike Havrilla's  Instablog

Mike Havrilla is an index developer, pharmacist, writer, and Co-Founder of BioMedReports.com with experience that includes online investing since August 1997 and writing for investors since April 2007 with a focus on the healthcare sector and small / micro-cap stocks. Mike holds Doctor of... More
My business:
ProActive HavRx BioFund
My blog:
BioMedReports.com FDA Calendar
My book:
ProActive HavRx Stock Indexes
  • Health IT Index Outperforms Market, Sector  2 comments
    May 8, 2009 05:58 PM | about stocks: ADAM, XLV, SPY, MDRX, CERN, ECLP, ATHN, MRGE, AAPL

    The ETF Innovators Health IT Index has been a strong performer over the past month, with many of the index components outpacing both the 12.7% gain in the S&P 500 ETF (NYSE:SPY) and the 6.5% gain in the Healthcare Sector SPDR (NYSE:XLV) during that period. The following are some top performing stocks from the index over the past month: Allscripts... (NASDAQ:MDRX) up 15.8%, Cerner (NASDAQ:CERN) up 33.2%, Eclipsys (NASDAQ:ECLP) up 64.9%, athenahealth (NASDAQ:ATHN) up 33.1%, and Merge Healthcare (NASDAQ:MRGE) up 39.4%.

     
    A recent addition to the Health IT Index is A.D.A.M. Inc. (Nasdaq:ADAM), which is up 16.1% in the past month. ADAM provides health information and tehcnology solutions for a wide variety of audiences, including consumers, employers, health benefit organizations, and educational institutions. The Company's products and services enable consumers to play an active role in their health and help to reduce healthcare costs for employers (Benergy System) and health benefit managers.
     
    In early May, the Company announced the introduction of a new swine flu topic to its online Multimedia Encyclopedia, which includes over 3,900 unique articles covering a wide variety of health topics that can be integrated into third-party websites. In late April, ADAM announced the availability of Medzio as a free mobile health application for Apple's (NASDAQ:AAPL) iPhone. The initial features include (1) first aid information, (2) interactive health information topics, (3) a search feature for local medical facilities, healthcare providers, and pharmacies, and (4) a mobile health network with information on healthcare pricing.
     
    ADAM will conduct its 1Q09 earnings conference call on Tuesday 5/12/09 at 10am (ET) with results released before the market open on the same day. The lone analyst estimate for the Company expects 1Q09 revenue of $7.1M and EPS of $0.09 with a full-year estimate of $28.9M for revenue and $0.36 for EPS. As of the market close on 5/8/09, ADAM has a market cap of about $33M and is trading at $3.31 per share.
     
    Disclosure: No positions.
     
     
    Themes: Health IT, ETF Innovators, Health IT Index Stocks: ADAM, XLV, SPY, MDRX, CERN, ECLP, ATHN, MRGE, AAPL
Back To Mike Havrilla's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

This post has 2 comments:

Full index of posts »
Latest Followers

StockTalks

More »
Posts by Ticker
AAPL, ABII, ABIO, ABT, ABV, ACAD, ACCP.OB, ACOR, ACUR, ACUS, ADAM, ADLS, AET, AEZS, AFFY, AGEN, AGN, ALKS, ALNY, ALPMF.PK, ALTH, ALXA, AMAG, AMGN, AMLN, AMRN, ANPI, APPA, APPY, ARDM.OB, ARKTF.PK, ARNA, ARUXF.PK, ARYX, ATHN, AUXL, AVNR, AZN, BAX, BAYRY.PK, BCRX, BDSI, BFRM, BIIB, BIOD, BMRN, BMTI, BMY, BPAX, BSX,

Latest Comments


Most Commented
  1. BioMedReports.com Mention in BusinessWeek (7 Comments)
  2. Sequenom Splattered, EXACT Sciences on the Rise (3 Comments)
  3. Who Will Take GM's Place in the Dow? (3 Comments)
  4. 13 Extreme FDA Trades: BioMedReports.com 6/1/09 Update (3 Comments)
  5. Mentor Capital: A Stealth Cancer Immunotherapy Play (3 Comments)
Posts by Themes
allos therapeutics, ANDA, ASCO, Avastin, BIO.PA, BioAlliance, biogenerics, biomed, BioMedReports.com, biotech, BLA, Botox, cancer, cancer biotech, cancer stock, China, cholesterol, Clean Energy, Clinical Trial, Clinical Trial Calendar, Clinical Trials, clinical trials, consumer staples, Crestor, DAVANAT, defensive, Dendreon, Diabetes, Discovery Labs, dividends, Dolphin Secure, Dysport, Enablex, ETF Innovators, Extreme Trades, Facebook, FDA, fda, FDA Calendar, Feraheme, Genentech, generic, Generic Drugs, Global Pharma, GTx, Health IT, Health IT Index, healthcare, Impax Labs, Impax Pharma,
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.